Vimta Labs informs about unaudited financial results

27 Oct 2022 Evaluate

Pursuant to Regulation 30 and 33 of SEBI (Listing obligations and disclosure requirements) 2015, Vimta Labs has informed that it enclosed Standalone and Consolidated Unaudited Financial Results for the second quarter / half year ended 30th September 2022, along with Limited Review Report. Copy of the Unaudited Financial results are also posted on the company’s website. Abridged financials are being published in the newspapers (copy enclosed). The meeting commenced at 10:00 am and ended at 2:30 pm.

The above information is a part of company’s filings submitted to BSE.

Vimta Labs Share Price

497.40 0.25 (0.05%)
24-May-2024 15:45 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1486.55
Dr. Reddys Lab 5860.25
Cipla 1482.55
Zydus Lifesciences 1072.35
Lupin 1613.65
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.